Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
NCT06132438
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
PEP-CMV vaccine
Sponsor
Charlotte Lemech
Collaborators
[object Object]